Neo Splice Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Seed
- Investors
-
1
Neo Splice Therapeutics General Information
Description
Operator of a biotechnology company intended to expand the druggable target universe by discovering and developing novel therapies focused on alternative RNA splicing and proteoforms. The company offers a therapeutics discovery and development platform that targets disease-specific proteoforms and mRNA splicing defects rather than traditional gene-centric approaches, enabling customers and partners in the healthcare and biopharmaceutical sectors to access innovative, targeted treatment options for complex conditions such as cancer.
Contact Information
Website
www.neosplicetx.comCorporate Office
- Kennesaw, GA
- United States
Corporate Office
- Kennesaw, GA
- United States
Neo Splice Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 28-Apr-2026 | Completed | Startup |
Neo Splice Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Neo Splice Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Neo Splice Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ACS BrightEdge | Corporate Venture Capital | Minority |
Neo Splice Therapeutics FAQs
-
When was Neo Splice Therapeutics founded?
Neo Splice Therapeutics was founded in 2025.
-
Where is Neo Splice Therapeutics headquartered?
Neo Splice Therapeutics is headquartered in Kennesaw, GA.
-
What is the size of Neo Splice Therapeutics?
Neo Splice Therapeutics has 2 total employees.
-
What industry is Neo Splice Therapeutics in?
Neo Splice Therapeutics’s primary industry is Biotechnology.
-
Is Neo Splice Therapeutics a private or public company?
Neo Splice Therapeutics is a Private company.
-
What is Neo Splice Therapeutics’s current revenue?
The current revenue for Neo Splice Therapeutics is .
-
Who are Neo Splice Therapeutics’s investors?
ACS BrightEdge has invested in Neo Splice Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
